Home >> Signaling Pathways >> TGF-β / Smad Signaling >> Bcr-Abl

Bcr-Abl

Bcl-Abl is a constitutively activated chimeric tyrosine kinase which is the genetic abnormality expressed in patient with CML (chronic myeloid leukemia).

Compare Products

product-structure
  1. Cat.No. Product Name Information
  2. A8605 1-Naphthyl PP1 Src family kinases inhibitor
  3. A8602 Adaphostin P210bcr/abl tyrosine kinase inhibitor
  4. B1011 Bafetinib (INNO-406) Bcr-Abl/Lyn tyrosine kinase inhibitor
  5. A2149 Bosutinib (SKI-606) Potent Abl/Src kinases
  6. A3017 Dasatinib (BMS-354825) Src and BCR-Abl inhibitor
  7. B5954 Dasatinib Monohydrate Inhibitor of ABL, SRC, KIT, PDGFR, and other tyrosine kinases.
  8. B1404 DCC-2036 (Rebastinib) Bcr-Abl inhibitor
  9. A8603 GNF 2 Bcr-Abl inhibitor
  10. A8604 GNF 5 Bcr-Abl inhibitor
  11. A1805 Imatinib Mesylate (STI571) Abl/c-kit/PDGFR inhibitor

Items 1 to 10 of 17 total

per page
  1. 1
  2. 2

Set Descending Direction